Treatment of Toxic Epidermal Necrolysis (TEN) with Low Dose Intravenous Immunoglobulin in Child

被引:0
|
作者
Habib, Aamir [1 ]
Pasha, Waseem [2 ]
Raza, Naeem [2 ]
机构
[1] Combined Mil Hosp, Dept Dermatol, Pano Aqil Cantt, Pakistan
[2] PAF Hosp Faisal, Dept Dermatol, Karachi, Pakistan
关键词
Stevens-Johnson syndrome; Toxic epidermal necrolysis; Intravenous immunoglobulin; Paediatrics; STEVENS-JOHNSON-SYNDROME;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN, Lyell's disease) are severe, episodic, acute mucocutaneous reaction that may be caused by various factors particularly drugs. Treatment is primarily supportive care and there are no specific therapy regimens. Intravenous immunoglobulin (IVIG) has recently been shown to be a useful and safe therapy in paediatric patients with SJS/TEN, though no such case has so far been reported from Pakistan. The authors report the experience with low dose IVIG (0.1 g/kg/day for four consecutive days for treating a 3 years old boy with toxic epidermal necrolysis with favourable outcome without early complications.
引用
收藏
页码:205 / 207
页数:3
相关论文
共 50 条
  • [31] Levofloxacin-induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin
    Teo, Wan Lin
    Pang, Shiu Ming
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (08) : 660 - 661
  • [32] Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin
    Boroda, Konstantin
    Li, Li
    Riina, Louis
    Ahmed, Shadab
    CUREUS, 2015, 7 (10):
  • [33] Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins
    Tan, A
    Tan, HH
    Lee, CC
    Ng, SK
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (03) : 269 - 271
  • [34] Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistoichemical study of Fas and Fas-Ligand expression
    Ito, K
    Hara, H
    Okada, T
    Shimojima, H
    Suzuki, H
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (06) : 679 - 680
  • [35] Early Treatment With Nonsucrose Intravenous Immunoglobulin in a Burn Unit Reduces Toxic Epidermal Necrolysis Mortality
    Aires, Daniel J.
    Fraga, Garth
    Korentager, Richard
    Richie, Coleman P.
    Aggarwal, Smita
    Wick, Jo
    Liu, Deede Y.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (06) : 679 - 684
  • [36] Toxic epidermal necrolysis (TEN) update
    Goh, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 3 - 3
  • [37] Interleukins and toxic epidermal necrolysis (TEN)
    Ventura, Viviana
    Posadinu, Alma
    Deiana, Marta
    Baralla, Angela
    Pasella, Sara
    Murgia, Luciano
    Pinna, Sara
    Canu, Elisabetta
    Marchisio, Andrea
    Zinellu, Angelo
    Carru, Ciriaco
    Deiana, Luca
    BIOCHIMICA CLINICA, 2014, 38 (01) : 65 - 69
  • [38] Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin
    Mehregan, Darius
    VanVreede, Anthony
    Goralewski, Mark
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (06) : E356 - E360
  • [39] Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN - The University of Miami experience
    Trent, JT
    Kirsner, RS
    Romanelli, P
    Kerdel, FA
    ARCHIVES OF DERMATOLOGY, 2003, 139 (01) : 39 - 43
  • [40] The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis
    Huang, Y. -C.
    Li, Y. -C.
    Chen, T. -J.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (02) : 424 - 432